Similar articles

• [Recommendations for the appropriate use of anti-TNFalpha therapy in patients with psoriatic arthritis. Italian Rheumatology Society].

  Salvarani C, Olivieri I, Cantini F, Marchesoni A, Punzi L, Scarpa R, Matucci-Cerinic M. Salvarani C, et al. Reumatismo. 2004 Jul-Sep;56(3):133-4, 136-8. Reumatismo. 2004. PMID: 15470517 Italian. No abstract available.
• Guideline for anti-TNF-alpha therapy in psoriatic arthritis.

  Kyle S, Chandler D, Griffiths CE, Helliwell P, Lewis J, McInnes I, Oliver S, Symmons D, McHugh N; British Society for Rheumatology Standards Guidelines Audit Working Group (SGAWG). Kyle S, et al. Rheumatology (Oxford). 2005 Mar;44(3):390-7. doi: 10.1093/rheumatology/keh514. Epub 2005 Feb 3. Rheumatology (Oxford). 2005. PMID: 15695305 Review. No abstract available.
• Anti-tumor necrosis factor alpha therapy in psoriatic arthritis and psoriasis.

  Girolomoni G, Abeni D. Girolomoni G, et al. Arch Dermatol. 2001 Jun;137(6):784-5. Arch Dermatol. 2001. PMID: 11405771 No abstract available.
• Do TNF-blockers reduce or induce uveitis?

  Cobo-Ibáñez T, del Carmen Ordóñez M, Muñoz-Fernández S, Madero-Prado R, Martín-Mola E. Cobo-Ibáñez T, et al. Rheumatology (Oxford). 2008 May;47(5):731-2. doi: 10.1093/rheumatology/ken091. Epub 2008 Mar 17. Rheumatology (Oxford). 2008. PMID: 18346974 No abstract available.
• TNFalpha inhibition in psoriatic arthritis: cause for hope.

  Zabraniecki L, Fournié B. Zabraniecki L, et al. Joint Bone Spine. 2001 Mar;68(2):106-8. doi: 10.1016/s1297-319x(01)00257-3. Joint Bone Spine. 2001. PMID: 11324924 Review. No abstract available.